Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandru Eniu

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
International Journal of Environmental Research and Public Health|April 12, 2022
Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer PatientsRadu Vidra, Tudor Eliade Ciuleanu, Adina Nemeș, et al.
JAMA Network Open|August 18, 2022
Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income CountriesFidel Rubagumya, Wilma M Hopman, Bishal Gyawali, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 22, 2018
Aberrant miRNAs expressed in HER-2 negative breast cancers patientCornelia Braicu, Lajos Raduly, Gabriela Morar-Bolba, et al.
The Oncologist|September 6, 2018
Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern EuropeEduard Vrdoljak, Gyorgy Bodoky, Jacek Jassem, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2018
Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planningMursheda Begum, Grant Lewison, Jacek Jassem, et al.
Cancer|June 29, 2023
Allocation of authorship and patient enrollment among global clinical trials in oncologyFidel Rubagumya, Adam Fundytus, Sophie Keith-Brown, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2023
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer careFatima Cardoso, Amelia McCartney, Antonio Ponti, et al.
The Oncologist|July 13, 2016
Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for ImprovementEduard Vrdoljak, Gyorgy Bodoky, Jacek Jassem, et al.
The Lancet. Oncology|August 10, 2016
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trialChristoph Zielinski, István Láng, Moshe Inbar, et al.
The Lancet. Oncology|June 9, 2017
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trialJustin Stebbing, Yauheni Baranau, Valeriy Baryash, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Environmental Research and Public Health|April 12, 2022
Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer PatientsRadu Vidra, Tudor Eliade Ciuleanu, Adina Nemeș, et al.
JAMA Network Open|August 18, 2022
Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income CountriesFidel Rubagumya, Wilma M Hopman, Bishal Gyawali, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 22, 2018
Aberrant miRNAs expressed in HER-2 negative breast cancers patientCornelia Braicu, Lajos Raduly, Gabriela Morar-Bolba, et al.
The Oncologist|September 6, 2018
Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern EuropeEduard Vrdoljak, Gyorgy Bodoky, Jacek Jassem, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2018
Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planningMursheda Begum, Grant Lewison, Jacek Jassem, et al.
Cancer|June 29, 2023
Allocation of authorship and patient enrollment among global clinical trials in oncologyFidel Rubagumya, Adam Fundytus, Sophie Keith-Brown, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2023
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer careFatima Cardoso, Amelia McCartney, Antonio Ponti, et al.
The Oncologist|July 13, 2016
Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for ImprovementEduard Vrdoljak, Gyorgy Bodoky, Jacek Jassem, et al.
The Lancet. Oncology|August 10, 2016
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trialChristoph Zielinski, István Láng, Moshe Inbar, et al.
The Lancet. Oncology|June 9, 2017
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trialJustin Stebbing, Yauheni Baranau, Valeriy Baryash, et al.
Pageof 7